Correvio Pharma Corp
Officers & Directors
1. Mark H.N. Low - Former CEO - Mr. Low was appointed as the CEO of Correvio Pharma in . He has over 25 years of experience in the pharmaceutical industry and has held senior leadership positions at companies such as Bausch Health and Valeant Pharmaceuticals. Mr. Low has a Bachelor of Science in Pharmacy from the University of British Columbia.
2. Shelly Guyer - Former CFO - Ms. Guyer was appointed as CFO in . She has over 20 years of experience as a CFO and financial executive in the pharmaceutical and healthcare industries. Prior to Correvio Pharma, Ms. Guyer held senior finance roles at companies such as Accera, Aytu BioScience, and Allos Therapeutics.
Former Directors:
1. David Allan - Former Chairman of the Board - Mr. Allan was the Chairman of the Board of Correvio Pharma from 2014 until 2020. He has over 30 years of experience in the pharmaceutical industry with a focus on cardiovascular drugs. Mr. Allan is also a board member of several other companies in the pharmaceutical and biotech sectors.
2. William Hunter - Former Director - Dr. Hunter was a Director of Correvio Pharma from 2017 until 2020. He has over 20 years of experience in the pharmaceutical industry and currently serves as the CEO of the biopharmaceutical company Axsome Therapeutics. Dr. Hunter has a medical degree from Columbia University and a Master's degree in Business Administration from the Wharton School of the University of Pennsylvania.
Correvio Pharma Corp currently has 108 employees.
|
